Skip to main content

Table 4 Improvement in A1C and medications after SG

From: Feasibility and impact of laparoscopic sleeve gastrectomy after renal transplantation on comorbidities, graft function and quality of life

Patients Type of DM Timing A1C Medications
Patient 2 T2D Pre-LSG 8.6 Biphasic insulin 70:30 (Novomix) 40 U daily
Post-LSG 6.4 Linagliptin 5 mg/day
Patient 3 T2D Pre-LSG 8 Biphasic insulin 70:30 (Novomix) 40 U daily
Post-LSG 6.2 Linagliptin 5 mg/day
Patient 5 T2D Pre-LSG 9 Biphasic insulin 70:30 (Novomix) 60 U daily
Post-LSG 6.7 Linagliptin 5 mg/day
  1. T2D diabetes mellitus type2, A1C glycosylated hemoglobin, LSG laparoscopic sleeve gastrectomy